Cleveland BioLabs Inc. (CBLI) Quarterly Performance is 49.20%: Here is the Surprise Factor

At the end of the latest market close, Cleveland BioLabs Inc. (CBLI) was valued at $1.90. In that particular session, Stock kicked-off at the price of $1.88 while reaching the peak value of $2.38 and lowest value recorded on the day was $1.88. The stock current value is $2.33.

Recently in News on June 3, 2020, Cleveland BioLabs Closes $3.175 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules. BUFFALO, NY / ACCESSWIRE / June 3, 2020 / Cleveland BioLabs, Inc. (CBLI), today announced the closing of its previously announced registered direct offering to several institutional and accredited investors of an aggregate of 1,515,878 shares of its common stock, at a purchase price of $2.0945 per share. The offering was priced at-the-market under Nasdaq rules. Cleveland BioLabs also issued to the investors unregistered warrants to purchase up to an aggregate of 757,939 shares of common stock. The warrants have an exercise price equal to $2.033 per share, are exercisable immediately upon issuance and will expire five years from the issuance date. You can read further details here

Cleveland BioLabs Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $5.00 on 02/27/20, with the lowest value was $0.51 for the same time period, recorded on 01/06/20.

Cleveland BioLabs Inc. (CBLI) full year performance was 128.43%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cleveland BioLabs Inc. shares are logging -53.40% during the 52-week period from high price, and 366.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.50 and $5.00.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1203004 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Cleveland BioLabs Inc. (CBLI) recorded performance in the market was 287.04%, having the revenues showcasing 49.20% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 24.70M, as it employees total of 7 workers.

Market experts do have their say about Cleveland BioLabs Inc. (CBLI)

During the last month, 0 analysts gave the Cleveland BioLabs Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.11, with a change in the price was noted +0.68. In a similar fashion, Cleveland BioLabs Inc. posted a movement of +41.21% for the period of last 100 days, recording 1,037,928 in trading volumes.

Technical breakdown of Cleveland BioLabs Inc. (CBLI)

Raw Stochastic average of Cleveland BioLabs Inc. in the period of last 50 days is set at 34.98%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 68.60%. In the last 20 days, the company’s Stochastic %K was 39.75% and its Stochastic %D was recorded 29.11%.

Bearing in mind the latest performance of Cleveland BioLabs Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 287.04%. Additionally, trading for the stock in the period of the last six months notably deteriorated by 0.00%, alongside a boost of 128.43% for the period of the last 12 months. The shares increased approximately by 41.21% in the 7-day charts and went up by -11.07% in the period of the last 30 days. Common stock shares were driven by 49.20% during last recorded quarter.